Načítá se...
Inhibitors of myelination and remyelination, bone morphogenetic proteins, are upregulated in human neurological disease.
During demyelinating disease such as multiple sclerosis and stroke, myelin is destroyed and along with it, the oligodendrocytes that synthesize the myelin. Thus, recovery is limited due to both interruptions in neuronal transmission as well as lack of support for neurons. Although oligodendrocyte pr...
Uloženo v:
| Vydáno v: | Neurochem Res |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7141772/ https://ncbi.nlm.nih.gov/pubmed/32030597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11064-020-02980-w |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|